[1 Announcement in relation to Closure of Register of Members and Withholding and Payment of Enterprise Income Tax for Non-resident Enterprises in respect of 2011 Final Dividend. 2 Announcement in relation to Adjustment to Convertible Bond Conversion Price.]
[CHINA BIOLOGIC PRODUCTS, INC. INDEPENDENT DIRECTOR AGREEMENT Agreement Company Director THIS AGREEMENT (The BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform the duties] [INDEMNIFICATION AGREEMENT Company Indemnitee This Indemnification Agreement, dated as of March 19, 2012, is made by and between China Biologic Products, Inc., a Delaware corporation (the RECITALS A. The Company and the Indemnitee recognize that the present state of the law is too uncertain to provide the Companys officers and directors with adequate and reliable advance knowledge or guidance] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): March 23, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building, 19 Chaoyang Park Road Chaoyang District, Beijing 100125 Peoples Republic of China (+86) 10-6598-3111 (Former name or former]
[JA Solar Announces Fourth Quarter and Fiscal Year 2011 Results · Fourth Quarter Shipments of 398MW and Full Year Shipments of 1.69GW · Cash & Cash Equivalents of $617.9 Million SHANGHAI, China, March 20, 2012 (GLOBE NEWSWIRE) JA Solar Holdings Co., Ltd., (Nasdaq:JASO), (JA Solar or the Company), one of the worlds largest manufacturers of high-performance solar cells and]
[JA Solar Announces Fourth Quarter and Fiscal Year 2011 Results · Fourth Quarter Shipments of 398MW and Full Year Shipments of 1.69GW · Cash & Cash Equivalents of $617.9 Million SHANGHAI, China, March 20, 2012 (GLOBE NEWSWIRE) JA Solar Holdings Co., Ltd., (Nasdaq:JASO), (JA Solar or the Company), one of the worlds largest manufacturers of high-performance solar cells and]
[Certain existing shareholders of our company, namely, the DCM Entities and the Sequoia Entities, have subscribed for, and have each been allocated by the underwriters, 1,538,460 ADSs in this offering at the initial public offering price and on the same terms as the other ADSs being offered in this offering. The underwriters expect to deliver the ADSs to purchasers on]
[Certain existing shareholders of our company, namely, the DCM Entities and the Sequoia Entities, have subscribed for, and have each been allocated by the underwriters, 1,538,460 ADSs in this offering at the initial public offering price and on the same terms as the other ADSs being offered in this offering. The underwriters expect to deliver the ADSs to purchasers on]
[Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho]
[Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho]
[Bona Film Group Reports Fourth Quarter and Full Year 2011 Financial Results BEIJING, March 1, 2012 Bona Film Group Limited, (Bona or the Company) (Nasdaq: BONA), a leading film distributor and vertically integrated film company in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2011. Fourth Quarter 2011 Financial Highlights] [Bona Film Group CFO Mason Xu to Step Down, Assume CEO Position for Investment Fund Bona has formed a CFO search committee consisting of Mr. Dong Yu, Bonas founder, chairman and chief executive officer, along with two of the Companys independent directors, Dr. Daqing Qi and Mr. Jie Lian. The committee has identified a number of CFO candidates and expects] [TABLE OF CONTENTS Press release: Bona Film Group Reports Fourth Quarter and Full Year 2011 Financial Results]
[SCHEDULE 14A Check the appropriate box: [X] Preliminary Proxy Statement [ ] Definitive Proxy Statement [ ] Definitiveditional Materials JF China Region Fund, _______________________________________ Payment of Filing Fee (Check the appropriate box): [X] No fee required [ ] Feemputed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11]
